NEWS / PRESS  
     
 

WOUNDTEK, INC ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH
SURGICAL PRICIPALS OF SEATTLE/TACOMA WASHINGTON

NEWPORT, RI, May 16, 2006 -- WoundTEK, Inc., a privately held medical device company, announced today that has entered into an exclusive agreement with Surgical Principals, Inc. to market and distribute it’s leading wound closure device throughout the West Coast.

The Agreement allows Surgical Principals to exclusively market and sell the S.T.A.R. device into this vast region. The S.T.A.R., (Suture Tension Adjustment Reel) is the first minimally invasive tissue expansion device for the closure of large open wounds caused by trauma and surgery.

"I am very optimistic about this relationship. Having Tim Wynne and the Surgical Principals team represent our company in this large and critical territory will have a tremendous impact on our business this year. The team members have been selling specialty medical products to surgical hospitals in this market for a very long time and they have over 20 sales people that have relationships with hundreds of hospitals. It represents a very large opportunity for us to grow our awareness and our market share rapidly.” Said Andrew Reilly, WoundTEK, Inc. Chief Executive.

“Surgical Principals has the ability to create markets for new and innovative surgical products. The opportunity that the S.T.A.R. device represents is very large and I think that we can help WoundTEK become a dominant player in the wound closure space.” Said Tim Wynn, Surgical Principals’ President. He continued; “We look forward to a long and prosperous relationship with WoundTEK.”

Surgical Principals, Inc., is a specialty surgical product distributor founded in September of 2000 by Tim Wynne. Mr. Wynne has significant experience in surgical sales and distribution. He founded Horizon Medical Technologies in 1992 and developed it into a leading specialty surgical products distributor. SPI currently employs fifteen sales representatives covering the states of AK, AZ, CA, CO, ID, MT, NM, NV, OR, UT, WA and WY.


WoundTEK, Inc based in Newport, RI is a medical device company focused on the closure of large wounds and skin deficits caused by trauma or surgery. The company manufactures the S.T.A.R. device; the first minimally invasive tissue approximation device. The S.T.A.R. brings to closure large wounds that cannot be closed using primary closure methods. Comprised of a winder reel and an anchor mechanism, joined by a simple mattress suture, the S.T.A.R. is able to rapidly expand tissue across large skin deficits with very little discomfort, closing large wounds faster and raising the level of patient care.

Large wound closure is a major health care problem worldwide and is one of the leading causes of deadly infections in the United States. Approximately 1,940,000 trauma cases and surgical procedures each year are faced with the challenge of closing large wounds and skin deficits. Current procedures to close large wounds can be technically demanding, increase the risk of infection, and be very invasive, painful, and have deep scaring effects to the tissue. The STAR System reduces many of the challenges that are currently faced by surgeons today.


# # #

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are necessarily estimates reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including the following: timing and success of product development and market acceptance of developed products; regulatory approvals, clearances and restrictions; guidelines and recommendations in the health care and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which WoundTEK operates; unanticipated manufacturing disruptions, delays in regulatory approvals of new manufacturing facilities or the inability to meet demand for products. Words such as "estimate," "project," "plan," "intend," "expect," "anticipate," "believe" and similar expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

 
     
     
   
 
 
 
 
   
© 2007 WoundTEK, Inc. All rights reserved.